Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02991898 · OUTCOME

Percentage of Donor Cell Chimerism

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies · Source last updated 2020-09-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
percentage of donor cells
Interval / dispersion
Full Range
Time frame
Day +100

What was measured

The incidence of chimerism in patients treated

Groups in this outcome

Treg Infusion

The Treg cell infusion is given no sooner than 1 hour, but within 24 hours after the 2nd cord blood infusion

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treg Infusion3

Reported measurements

Source class 1
Values in percentage of donor cells · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Treg Infusion72Not reported50100Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        50
        upper Limit
        100
        value
        72
denoms
  1. counts
    1. group Id
      OG000
      value
      3
    units
    Participants
description
The incidence of chimerism in patients treated
dispersion Type
Full Range
groups
  1. description
    The Treg cell infusion is given no sooner than 1 hour, but within 24 hours after the 2nd cord blood infusion
    id
    OG000
    title
    Treg Infusion
param Type
MEAN
reporting Status
POSTED
time Frame
Day +100
title
Percentage of Donor Cell Chimerism
type
SECONDARY
unit Of Measure
percentage of donor cells

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice